Predictors of Mortality in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

@article{Barman2014PredictorsOM,
  title={Predictors of Mortality in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization},
  author={Pranab M. Barman and Pratima Sharma and Venkat N Krishnamurthy and Jonathon Willatt and Heather M McCurdy and Richard H. Moseley and Grace L. Su},
  journal={Digestive Diseases and Sciences},
  year={2014},
  volume={59},
  pages={2821-2825}
}
Transarterial chemoembolization (TACE) is the recommended treatment for patients with Barcelona stage B hepatocellular carcinoma; however, community practice varies from these American Association for the Study of Liver Diseases guidelines. In this study, we sought to assess factors determining outcome after TACE and examine adherence to guidelines. From January 2006 to December 2012, 308 patients with newly diagnosed HCC were treated at the Veterans Affairs (VA) Ann Arbor Healthcare System. Of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Association for the Study of Liver Diseases, Management of hepatocellular carcinoma: an update

  • J Bruix, M Sherman, D. American
  • Hepatology
  • 2011
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…